Crystal form of dabrafenib and preparation method and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458149
APP PUB NO 20160207911A1
SERIAL NO

15081498

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to Crystal Form VII of dabrafenib and preparation method thereof, wherein Crystal Form VII has the advantage of being more stable at room temperature or in aqueous systems, and has low hygroscopicity, and thus is more suitable for a wet granulation process or being prepared into a suspension; and the present invention also relates to a pharmaceutical composition and formulations comprising Crystal Form VII, and their use in the treatment of Raf family kinase-related diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANGZHOU SOLIPHARMA CO LTDSUITE 2B05 BUILDING 1 NO 452 6TH AVE HANGZHOU ECONOMIC AND TECHNOLOGY DEVELOPMENT AREA HANGZHOU ZHEJIANG 310018

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lao, Haiping Hangzhou, CN 4 5
Sheng, Xiaohong Hangzhou, CN 34 32
Sheng, Xiaoxia Hangzhou, CN 40 132

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00